These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31509566)

  • 1. Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts.
    Dias HB; de Oliveira JR; Donadio MVF; Kimura S
    PLoS One; 2019; 14(9):e0222202. PubMed ID: 31509566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gal-1-mediated cytochrome p450 activation promotes fibroblast into myofibroblast differentiation in pulmonary fibrosis.
    Weng J; Cheng Q; Yang J; Jin H; Zhang R; Guan J; Ma Y; Wang L; Chen C; Wang Z
    Int Immunopharmacol; 2024 Nov; 141():112920. PubMed ID: 39137631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose-1,6-Bisphosphate Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice and Inhibits the Proliferation of Lung Fibroblasts.
    Jost RT; Dias HB; Krause GC; de Souza RG; de Souza TR; Nuñez NK; Dos Santos FG; Haute GV; da Silva Melo DA; Pitrez PM; da Silva VD; Donadio MVF; de Oliveira JR
    Inflammation; 2018 Oct; 41(5):1987-2001. PubMed ID: 29995294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
    Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
    J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway.
    Han X; Yuan T; Zhang J; Shi Y; Li D; Dong Y; Fan S
    J Cell Mol Med; 2022 Jun; 26(11):3269-3280. PubMed ID: 35510614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition.
    Lu GX; Bian DF; Ji Y; Guo JM; Wei ZF; Jiang SD; Xia YF; Dai Y
    Phytother Res; 2014 Aug; 28(8):1224-31. PubMed ID: 24458872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Endothelial-to-Mesenchymal Transition Induction by Extracellular Matrix Components in Pulmonary Fibrosis.
    Grigorieva OA; Vigovskiy MA; Dyachkova UD; Basalova NA; Aleksandrushkina NA; Kulebyakina MA; Zaitsev IL; Popov VS; Efimenko AY
    Bull Exp Biol Med; 2021 Aug; 171(4):523-531. PubMed ID: 34542758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of Ramelteon on bleomycin-induced pulmonary fibrosis in mice.
    Zhang L; Cheng T; Chen W; Zhong C; Li M; Xie Y; Deng Q; Wang H; Yang Z; Ju J; Liang H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4153-4163. PubMed ID: 38032492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation.
    Chen G; Li J; Liu H; Zhou H; Liu M; Liang D; Meng Z; Gan H; Wu Z; Zhu X; Han P; Liu T; Gu R; Liu S; Dou G
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
    Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
    Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats.
    Wang Y; Huang G; Mo B; Wang C
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.